|
|
|
Corporate Profile: Pharminox
| Summary: |
Pharminox is focused on the discovery, research, and development of small molecule drugs focused on DNA damage and inhibition of DNA repair to treat patients with cancer.
|
| Address (HQ): |
BioCity Nottingham
Pennyfoot Street
Nottingham,
NG1 1GF
United Kingdom |
| Phone
#'s (HQ): |
| Main |
+44 (0)1428 645416 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
+44 (0)1428 645416 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
